GURUFOCUS.COM » STOCK LIST » USA » NAS » Syneos Health Inc (NAS:SYNH) » Definitions » Piotroski F-Score
Switch to:

Syneos Health Piotroski F-Score

: 8 (As of Today)
View and export this data going back to 2014. Start your Free Trial

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Syneos Health has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Syneos Health's Piotroski F-Score or its related term are showing as below:

SYNH' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 9
Current: 8

During the past 11 years, the highest Piotroski F-Score of Syneos Health was 9. The lowest was 3. And the median was 6.


Syneos Health Piotroski F-Score Historical Data

The historical data trend for Syneos Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 9.00 6.00 8.00

Syneos Health Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 8.00 7.00 8.00

Competitive Comparison

For the Diagnostics & Research subindustry, Syneos Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Syneos Health Piotroski F-Score Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Syneos Health's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun22) TTM:Last Year (Jun21) TTM:
Net Income was 78.243 + 75.959 + 46.176 + 77.744 = $278 Mil.
Cash Flow from Operations was 48.504 + 185.979 + 70.887 + 99.902 = $405 Mil.
Revenue was 1348.23 + 1373.384 + 1336.253 + 1360.739 = $5,419 Mil.
Gross Profit was 316.343 + 348.618 + 291.821 + 325.842 = $1,283 Mil.
Average Total Assets from the begining of this year (Jun21)
to the end of this year (Jun22) was
(8019.674 + 8216.959 + 8237.093 + 8303.961 + 8216.672) / 5 = $8198.8718 Mil.
Total Assets at the begining of this year (Jun21) was $8,020 Mil.
Long-Term Debt & Capital Lease Obligation was $3,043 Mil.
Total Current Assets was $1,882 Mil.
Total Current Liabilities was $1,707 Mil.
Net Income was 63.416 + 91.886 + 38.724 + 41.905 = $236 Mil.

Revenue was 1099.004 + 1140.019 + 1208.745 + 1282.611 = $4,730 Mil.
Gross Profit was 278.776 + 292.011 + 263.495 + 290.03 = $1,124 Mil.
Average Total Assets from the begining of last year (Jun20)
to the end of last year (Jun21) was
(7407.131 + 7384.731 + 8063.306 + 7954.649 + 8019.674) / 5 = $7765.8982 Mil.
Total Assets at the begining of last year (Jun20) was $7,407 Mil.
Long-Term Debt & Capital Lease Obligation was $3,107 Mil.
Total Current Assets was $1,748 Mil.
Total Current Liabilities was $1,596 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Syneos Health's current Net Income (TTM) was 278. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Syneos Health's current Cash Flow from Operations (TTM) was 405. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun21)
=278.122/8019.674
=0.03467996

ROA (Last Year)=Net Income/Total Assets (Jun20)
=235.931/7407.131
=0.03185187

Syneos Health's return on assets of this year was 0.03467996. Syneos Health's return on assets of last year was 0.03185187. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Syneos Health's current Net Income (TTM) was 278. Syneos Health's current Cash Flow from Operations (TTM) was 405. ==> 405 > 278 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=3043.214/8198.8718
=0.37117473

Gearing (Last Year: Jun21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun20 to Jun21
=3106.842/7765.8982
=0.40006216

Syneos Health's gearing of this year was 0.37117473. Syneos Health's gearing of last year was 0.40006216. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun22)=Total Current Assets/Total Current Liabilities
=1881.871/1707.459
=1.10214711

Current Ratio (Last Year: Jun21)=Total Current Assets/Total Current Liabilities
=1748.296/1596.348
=1.09518476

Syneos Health's current ratio of this year was 1.10214711. Syneos Health's current ratio of last year was 1.09518476. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Syneos Health's number of shares in issue this year was 103.072. Syneos Health's number of shares in issue last year was 105.019. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1282.624/5418.606
=0.23670737

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1124.312/4730.379
=0.23767905

Syneos Health's gross margin of this year was 0.23670737. Syneos Health's gross margin of last year was 0.23767905. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun21)
=5418.606/8019.674
=0.67566412

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun20)
=4730.379/7407.131
=0.638625

Syneos Health's asset turnover of this year was 0.67566412. Syneos Health's asset turnover of last year was 0.638625. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+1+0+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Syneos Health has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Syneos Health  (NAS:SYNH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Syneos Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Syneos Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health Business Description

Syneos Health logo
Traded in Other Exchanges
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Executives
Zulueta Alfonso G director LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Bodem Barbara W. director C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277
Brooks Michael Lee officer: See remarks C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Wilkes David S. director ONE BAXTER PARKWAY DEERFIELD IL 60015
Connaughton Bernadette director C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139
Klitgaard William E director 210 CARNEGIE CENTER PRINCETON NJ 08540
Meyers Kenneth F director 275 NORTH FIELD DRIVE LAKE FOREST IL 60045
Monaghan Matthew E. director ONE INVACARE WAY ELYRIA OH 44035
Harty Linda S director MEDTRONIC PLC 710 MEDTRONIC PARKWAY NE, LC-150 MINNEAPOLIS MN 55432
Kralowetz Donna Hildebrand officer: SVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Colvin Paul officer: Pres., Clinical Solutions C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Parks Robert officer: EVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Olefson Jonathan officer: General Counsel & Corp Secty C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Meggs Jason M. officer: Chief Financial Officer C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Gpe Vii Gp S.a.r.l. 10 percent owner CO ADVENT INTERNATIONAL 800 BOYLSTON STREET BOSTON MA 02199

Syneos Health Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)